Vaccines that Protect Against Infectious Respiratory Diseases

Most vaccine-preventable diseases are spread from person to person, which means that if one person in a community gets an infectious disease, they can spread it to others. The best way to help stop the spread of certain diseases is through vaccination. If enough people are vaccinated there are fewer chances for a vaccine-preventable disease to spread, keeping everyone healthier.

There are vaccines for some infectious respiratory diseases, including:

Some infectious respiratory diseases do not yet have a vaccine, including:

Talk to your doctor to see if you are up to date on your vaccinations.  It’s always better to prevent a disease rather than treat it after it occurs.

Vaccine Finder

The HealthMap Vaccine Finder provides information on where to get vaccinations. Go to the vaccine finder and enter your zip code to find mapped locations, dates, times, addresses and phone numbers for clinics offering adult vaccinations near you.

Reduce Your Risk for the Flu

In addition, you can find locations offering flu shots near you—and transportation if you need it—by visiting My-Flu-Shot.com for more information.

A History of Vaccines

Vaccines have a long and impressive history. Well before we understood how infections worked, in the late 1700s an English physician Edward Jenner learned that giving small amounts of infected material from smallpox victims to others provided them protection from the dreaded disease. It was from those learnings that he developed a smallpox vaccine saving countless lives and small-pox has now been eradicated worldwide. Since that first vaccine was developed in 1798, we have used that same principle to produce vaccines to almost eliminate many of the formerly deadly childhood infectious diseases from the U.S.  In fact, the greatest vaccine success in the modern era has been the near worldwide elimination of polio.

But it’s not always that simple. Try as we might, we have not yet been able to develop successful vaccines to control other important worldwide infections, such as tuberculosis (TB), malaria and HIV. In addition, controlling influenza also remains a challenge requiring new vaccines each flu season. Most recently, scientists are working tirelessly to create a vaccine to stop the COVID-19 pandemic.

How Vaccines Are Approved

Vaccine and new drug testing are overseen by the Food and Drug Administration (FDA) and are done in a similar way. 

Pre-clinical/ Laboratory study

First, the vaccine is tested in cells or animals to see if it can elicit an immune response and identify any serious side effects. If animal testing seems safe and effective, this is when a group submits their study to the FDA for approval to move on to the next stage of testing.

Phase I

This stage is randomized, diverse, controlled and include a larger number of participants. Individuals may include children, elderly, and other high-risk groups. The goal of this phase is to determine what variables may affect the safety of the vaccine, differences in immune responses, as well as the most effective dosage size and delivery method.

Phase II

These trials are similar to Phase II but they can involve tens of thousands of individuals. Researchers give the new medicine or treatment to an even larger group of participants to confirm its effectiveness, monitor side effects, and collect information that will allow the new medicine or treatment to be used safely.

Phase III

These trials are similar to Phase II but they can involve tens of thousands of individuals. Researchers give the new medicine or treatment to an even larger group of participants to confirm its effectiveness, monitor side effects, and collect information that will allow the new medicine or treatment to be used safely.

Approval

After a successful Phase III, the FDA will review the results and decide whether or not to approve it. Though each vaccine has a different benchmark for success, if the vaccinee goes through all phases and is found to be safe and effective, the FDA will then license the vaccine for distribution. Once licensed, the FDA will continue to monitor the production, potency and effectiveness of the vaccine. This may include Phase IV trials, monitoring manufacturing facilities, Vaccine Adverse Event Reporting system, Vaccine Safety Datalink monitoring VSAFE a new smartphone-based, after-vaccination health checker for people who receive COVID-19 vaccines.

Emergency Use Authorization

If the need for the vaccine is urgent, such as the COVID-19 vaccines currently in or having completed Phase III testing, and the vaccine is found to be effective, the FDA may give preliminary or conditional approval before all the testing is completed. But this will only happen if positive results are being shown throughout all phases of testing. Adverse events are also noted and evaluated to see if they impact authorization. For an EUA to be issued for a vaccine, for which there is adequate manufacturing information to ensure quality and consistency, FDA must determine that the known and potential benefits outweigh the known and potential risks of the vaccine.

Emergency Use Authorization for Vaccines Explained | FDA

Learn more by searching for recent vaccine topics covered in our Each Breath blog.

Still Have Questions?

Contact our Lung HelpLine at 1-800-LUNGUSA for one-on-one support, or submit your question online.
Contact Us

COVID-19 Vaccine Tracker

Science-based information to help you stay informed about the safety and availability of a COVID-19 vaccine.
Learn More

Thank You To Our Partner

Page last updated: February 23, 2021

No upcoming events near you